811 related articles for article (PubMed ID: 33950403)
1. Breast cancer organoids from malignant pleural effusion-derived tumor cells as an individualized medicine platform.
Pan B; Zhao D; Liu Y; Li N; Song C; Li N; Li X; Zhao Z
In Vitro Cell Dev Biol Anim; 2021 May; 57(5):510-518. PubMed ID: 33950403
[TBL] [Abstract][Full Text] [Related]
2. Establishment of Patient-Derived Organoids Using Ascitic or Pleural Fluid from Cancer Patients.
Choi W; Kim YH; Woo SM; Yu Y; Lee MR; Lee WJ; Chun JW; Sim SH; Chae H; Shim H; Lee KS; Kong SY
Cancer Res Treat; 2023 Oct; 55(4):1077-1086. PubMed ID: 37309112
[TBL] [Abstract][Full Text] [Related]
3. Advancing Cancer Therapy Predictions with Patient-Derived Organoid Models of Metastatic Breast Cancer.
Önder CE; Ziegler TJ; Becker R; Brucker SY; Hartkopf AD; Engler T; Koch A
Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509265
[TBL] [Abstract][Full Text] [Related]
4. A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity.
Sachs N; de Ligt J; Kopper O; Gogola E; Bounova G; Weeber F; Balgobind AV; Wind K; Gracanin A; Begthel H; Korving J; van Boxtel R; Duarte AA; Lelieveld D; van Hoeck A; Ernst RF; Blokzijl F; Nijman IJ; Hoogstraat M; van de Ven M; Egan DA; Zinzalla V; Moll J; Boj SF; Voest EE; Wessels L; van Diest PJ; Rottenberg S; Vries RGJ; Cuppen E; Clevers H
Cell; 2018 Jan; 172(1-2):373-386.e10. PubMed ID: 29224780
[TBL] [Abstract][Full Text] [Related]
5. Clinical importance of serum and pleural fluid prominin-1 and hypoxia-inducible factor-1α concentration in the evaluation of lymph node involvement in patients with malignant pleural effusion.
Ozmen ZC; Kupeli M
Biochem Med (Zagreb); 2023 Oct; 33(3):030701. PubMed ID: 37841777
[TBL] [Abstract][Full Text] [Related]
6. Precision Immunotherapy Utilizing Adapter CAR-T Cells (AdCAR-T) in Metastatic Breast Cancer Leads to Target Specific Lysis.
Önder CE; Moustafa-Oglou M; Schröder SM; Hartkopf AD; Koch A; Seitz CM
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201595
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer organoids from a patient with giant papillary carcinoma as a high-fidelity model.
Li X; Pan B; Song X; Li N; Zhao D; Li M; Zhao Z
Cancer Cell Int; 2020; 20():86. PubMed ID: 32206037
[TBL] [Abstract][Full Text] [Related]
8. Optimizing individualized treatment strategy based on breast cancer organoid model.
Pan B; Li X; Zhao D; Li N; Wang K; Li M; Zhao Z
Clin Transl Med; 2021 Apr; 11(4):e380. PubMed ID: 33931968
[No Abstract] [Full Text] [Related]
9. Establishment and characterization of breast cancer organoids from a patient with mammary Paget's disease.
Pan B; Zhao D; Liu Y; Li N; Song C; Li N; Li X; Li M; Zhao Z
Cancer Cell Int; 2020; 20():365. PubMed ID: 32774159
[TBL] [Abstract][Full Text] [Related]
10. Human lung adenocarcinoma cell cultures derived from malignant pleural effusions as model system to predict patients chemosensitivity.
Roscilli G; De Vitis C; Ferrara FF; Noto A; Cherubini E; Ricci A; Mariotta S; Giarnieri E; Giovagnoli MR; Torrisi MR; Bergantino F; Costantini S; Fenizia F; Lambiase M; Aurisicchio L; Normanno N; Ciliberto G; Mancini R
J Transl Med; 2016 Feb; 14():61. PubMed ID: 26928703
[TBL] [Abstract][Full Text] [Related]
11. The TRIPLEX study: use of patient-derived tumor organoids as an innovative tool for precision medicine in triple-negative breast cancer.
Divoux J; Florent R; Jacobs M; Lequesne J; Grellard JM; San C; Grossi S; Kerdja K; Clarisse B; Boudier G; Cherifi F; Briand M; Dolivet E; Johnson A; Dubois B; Harter V; Lacroix J; Raboutet C; Marie B; Rousseau N; Blanc-Fournier C; Vaur D; Figeac M; Poulain L; Weiswald LB; Emile G
BMC Cancer; 2023 Sep; 23(1):883. PubMed ID: 37726786
[TBL] [Abstract][Full Text] [Related]
12. Malignant pleural effusion supernatant is an alternative liquid biopsy specimen for comprehensive mutational profiling.
Guo Z; Xie Z; Shi H; Du W; Peng L; Han W; Duan F; Zhang X; Chen M; Duan J; Lin J; Chen X; Lizaso AA; Han-Zhang H; He J; Yin W
Thorac Cancer; 2019 Apr; 10(4):823-831. PubMed ID: 30779318
[TBL] [Abstract][Full Text] [Related]
13. Patient-Derived Triple-Negative Breast Cancer Organoids Provide Robust Model Systems That Recapitulate Tumor Intrinsic Characteristics.
Bhatia S; Kramer M; Russo S; Naik P; Arun G; Brophy K; Andrews P; Fan C; Perou CM; Preall J; Ha T; Plenker D; Tuveson DA; Rishi A; Wilkinson JE; McCombie WR; Kostroff K; Spector DL
Cancer Res; 2022 Apr; 82(7):1174-1192. PubMed ID: 35180770
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of EGFR mutations detected in malignant pleural effusion, plasma and tumor tissue in patients with adenocarcinoma of the lung.
Wang S; Chen H; Zhong J; Qin H; Bai H; Zhao J; Wang J
Lung Cancer; 2019 Sep; 135():116-122. PubMed ID: 31446983
[TBL] [Abstract][Full Text] [Related]
15. Intrapleural paclitaxel for malignant pleural effusion from ovarian and breast cancer: a phase II study with pharmacokinetic analysis.
Lombardi G; Nicoletto MO; Gusella M; Fiduccia P; Dalla Palma M; Zuin A; Fiore D; Donach M; Zagonel V
Cancer Chemother Pharmacol; 2012 Mar; 69(3):781-7. PubMed ID: 22037881
[TBL] [Abstract][Full Text] [Related]
16. Patient-Derived Organoids Can Guide Personalized-Therapies for Patients with Advanced Breast Cancer.
Chen P; Zhang X; Ding R; Yang L; Lyu X; Zeng J; Lei JH; Wang L; Bi J; Shao N; Shu D; Wu B; Wu J; Yang Z; Wang H; Wang B; Xiong K; Lu Y; Fu S; Choi TK; Lon NW; Zhang A; Tang D; Quan Y; Meng Y; Miao K; Sun H; Zhao M; Bao J; Zhang L; Xu X; Shi Y; Lin Y; Deng C
Adv Sci (Weinh); 2021 Nov; 8(22):e2101176. PubMed ID: 34605222
[TBL] [Abstract][Full Text] [Related]
17. Model of Patient-Specific Immune-Enhanced Organoids for Immunotherapy Screening: Feasibility Study.
Votanopoulos KI; Forsythe S; Sivakumar H; Mazzocchi A; Aleman J; Miller L; Levine E; Triozzi P; Skardal A
Ann Surg Oncol; 2020 Jun; 27(6):1956-1967. PubMed ID: 31858299
[TBL] [Abstract][Full Text] [Related]
18. Expression, correlation, and prognostic value of TRAF2 and TRAF4 expression in malignant plural effusion cells in human breast cancer.
Zhao ZJ; Ren HY; Yang F; Wang J; Wu GP; Mi XY
Diagn Cytopathol; 2015 Nov; 43(11):897-903. PubMed ID: 26331901
[TBL] [Abstract][Full Text] [Related]
19. Detecting EGFR mutations and ALK/ROS1 rearrangements in non-small cell lung cancer using malignant pleural effusion samples.
Yao Y; Peng M; Shen Q; Hu Q; Gong H; Li Q; Zheng Z; Xu B; Li Y; Dong Y
Thorac Cancer; 2019 Feb; 10(2):193-202. PubMed ID: 30565433
[TBL] [Abstract][Full Text] [Related]
20. Useful Application of Immunostaining to Malignant Pleural Effusion among Lao People in Vientiane Capital, Lao PDR.
Vilayvong S; Hando K; Sekine M; Luangxay T; Arounlangsy P; Xaysomphet P; Xayaphet P; Thavisouk H; Soejima Y; Kitagawa M; Sawabe M
Asian Pac J Cancer Prev; 2019 Jan; 20(1):243-248. PubMed ID: 30678439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
